December 5, 2019

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

Reports

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

December 5, 2019

FTSE 100

Funds

Day: December 5, 2019